Donnie Rudd
Keine laufenden Positionen mehr
Profil
Dr. Donnie Rudd is Chief Scientific Officer at Regenetech, Inc. and Chief Scientist & Director-Intellectual Property at Endonovo Therapeutics, Inc.
He received his undergraduate degree from Texas A&M University and a graduate degree from the Chicago-Kent College of Law.
Ehemalige bekannte Positionen von Donnie Rudd
| Unternehmen | Position | Ende |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Regenetech, Inc.
 Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Donnie Rudd
| Texas A&M University | Undergraduate Degree |
| Chicago-Kent College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Regenetech, Inc.
Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Commercial Services |
